1-adamantylazetidin-2-one derivatives and drugs containing same
AssigneeKowa Company, Ltd.
InventorsHisashi Nakashima, Takahiro Mori, Takaaki Araki, Takahisa Ogamino, Kazutoyo Abe, Tadaaki Ohgiya, Ryoko Mori
Life of this patent
Estimating the term…
Loading patent…
AssigneeKowa Company, Ltd.
InventorsHisashi Nakashima, Takahiro Mori, Takaaki Araki, Takahisa Ogamino, Kazutoyo Abe, Tadaaki Ohgiya, Ryoko Mori
Estimating the term…
It is to provide a novel compound useful for preventing and/or treating diseases that involves 11β-hydroxysteroid dehydrogenase 1, particularly diabetes, insulin resistance, diabetes complication, obesity, dyslipidemia, hypertension, fatty liver, or metabolic syndrome. It is an 1-adamantyl azetidin-2-one derivative represented by the following general formula (1) or salt thereof, or their solvate. [wherein A ring represents C6-10 aryl group, 5- to 14-membered heteroaryl group, R1 is a hydrogen atom, halogen atom, C1-6 alkoxycarbonyl group, hydroxyl group, carboxyl group or carbamoyl group; R2 and R3 are the same or different and are a C1-6 alkyl group; R4, R5, and R6 are same or different, and are a hydrogen atom, halogen atom, C1-6 alkyl group, C1-6 alkoxy group, C6-10 aryl group, or R4 and R5, or R5 and R6 may together form a C1-3 alkylenedioxy group, R7 and R8 are the same of different and represent a hydrogen atom or C1-6 alkyl group, or may together form a C3-6 cyclic hydrocarbon group, n represents an integer of 0 or 1]
An 1-adamantyl azetidin-2-one derivative represented by the following general formula (1) or salt thereof, or their solvate.
Dependencies are inferred from the claim text.